Prevalence and determinants of psychological insulin resistance among type 2 diabetic patients in Kinshasa, Democratic Republic of Congo

African Journal of Primary Health Care & Family Medicine

 
 
Field Value
 
Title Prevalence and determinants of psychological insulin resistance among type 2 diabetic patients in Kinshasa, Democratic Republic of Congo
 
Creator Rita, Shomba L. Lubaki, Fina J.-P. Bompeka, Lepira F. Ogunbanjo, Gboyega A. Ngwala, Lukanu P.
 
Subject family medicine; primary health care psychological insulin resistance, therapy; type 2 diabetes mellitus; frequency; determinants
Description Background: Psychological insulin resistance (PIR) is a common but unappreciated phenomenon by health care providers with a negative impact on the control of type 2 diabetes mellitus.Aim: To determine the frequency of PIR and its determinants in patients with type 2 diabetes.Setting: This study was conducted in Kinshasa in three health centres providing management of diabetic patients.Methods: This study was a multicentric, cross-sectional study conducted from 01 November 2017 to 31 March 2018 in Kinshasa among 213 type 2 diabetic patients who were taking oral anti-diabetic drugs. A standardised questionnaire, the Chinese Attitudes to Starting Insulin Questionnaire (Ch-ASIQ), was used for data collection.Results: The average age of participants was 59.8 ± 11.1 years with a male to female ratio of 1.5. The prevalence of PIR was 42.7%; and its main determinants were 50 years of age (odds ratios [OR] adjusted 2.05; 95% confidence interval [CI] 1.98–4.27; p = 0.045), the presence of complications (OR adjusted 3.33; 95% CI 1.68–6.60; p = 0.001), lack of knowledge about insulin therapy (OR adjusted 1.96; 95% CI 1.03–3.71; p = 0.040) and the high cost of insulin (OR adjusted 2.32; 95% CI 1.08–4.95; p = 0.030).Conclusion: The study showed that almost half of type 2 diabetic patients had PIR with the main determinant factors related to the patient and the health system. The establishment of a therapeutic education programme, improved ‘provider–patient’ communication and the development of approaches to increase access to drugs are crucial to reduce the prevalence of PIR.
 
Publisher AOSIS
 
Contributor
Date 2019-07-22
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — cross sectional
Format text/html application/epub+zip text/xml application/pdf
Identifier 10.4102/phcfm.v11i1.1993
 
Source African Journal of Primary Health Care & Family Medicine; Vol 11, No 1 (2019); 5 pages 2071-2936 2071-2928
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://phcfm.org/index.php/phcfm/article/view/1993/3219 https://phcfm.org/index.php/phcfm/article/view/1993/3218 https://phcfm.org/index.php/phcfm/article/view/1993/3220 https://phcfm.org/index.php/phcfm/article/view/1993/3217
 
Coverage Africa 2017 - 2018 age; gender; study level; income
Rights Copyright (c) 2019 Shomba L. Rita, Fina J.-P. Lubaki, Lepira F. Bompeka, Ogunbanjo A. Gboyega, Lukanu P. Ngwala https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT